Clinical Trial Update: Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluated the combination of clofarabine and cyclophosphamide in patients with acute lymphoblastic leukemia, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma

Drugs mentioned

• Clolar (Clofarabine)
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Burkitt's Lymphoma, Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-04